File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Medialization thyroplasty for cancer-related unilateral vocal fold paralysis

TitleMedialization thyroplasty for cancer-related unilateral vocal fold paralysis
Authors
Issue Date2007
PublisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/ohns
Citation
Otolaryngology - Head And Neck Surgery, 2007, v. 136 n. 3, p. 440-444 How to Cite?
AbstractObjective: To justify the application of medialization thyroplasty in Chinese patients with symptomatic cancer-related unilateral vocal fold paralysis (UVFP). Study design and setting: Retrospective chart review from February 2000 to March 2006. Results: Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040). Conclusion: Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable. Significance: Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP. © 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Persistent Identifierhttp://hdl.handle.net/10722/84435
ISSN
2015 Impact Factor: 2.021
2015 SCImago Journal Rankings: 1.176
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLam, PKYen_HK
dc.contributor.authorHo, WKen_HK
dc.contributor.authorNg, MLen_HK
dc.contributor.authorWei, WIen_HK
dc.date.accessioned2010-09-06T08:52:56Z-
dc.date.available2010-09-06T08:52:56Z-
dc.date.issued2007en_HK
dc.identifier.citationOtolaryngology - Head And Neck Surgery, 2007, v. 136 n. 3, p. 440-444en_HK
dc.identifier.issn0194-5998en_HK
dc.identifier.urihttp://hdl.handle.net/10722/84435-
dc.description.abstractObjective: To justify the application of medialization thyroplasty in Chinese patients with symptomatic cancer-related unilateral vocal fold paralysis (UVFP). Study design and setting: Retrospective chart review from February 2000 to March 2006. Results: Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040). Conclusion: Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable. Significance: Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP. © 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation.en_HK
dc.languageengen_HK
dc.publisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/ohnsen_HK
dc.relation.ispartofOtolaryngology - Head and Neck Surgeryen_HK
dc.rightsOtolaryngology - Head and Neck Surgery. Copyright © Mosby, Inc.en_HK
dc.titleMedialization thyroplasty for cancer-related unilateral vocal fold paralysisen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0194-5998&volume=136&spage=440&epage=444&date=2007&atitle=Medialization+thyroplasty+for+cancer-related+unilateral+vocal+fold+paralysisen_HK
dc.identifier.emailNg, ML: manwa@hku.hken_HK
dc.identifier.emailWei, WI: hrmswwi@hku.hken_HK
dc.identifier.authorityNg, ML=rp00942en_HK
dc.identifier.authorityWei, WI=rp00323en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.otohns.2006.11.009en_HK
dc.identifier.pmid17321874-
dc.identifier.scopuseid_2-s2.0-33847092534en_HK
dc.identifier.hkuros126163en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33847092534&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume136en_HK
dc.identifier.issue3en_HK
dc.identifier.spage440en_HK
dc.identifier.epage444en_HK
dc.identifier.isiWOS:000244793200019-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridLam, PKY=7202366058en_HK
dc.identifier.scopusauthoridHo, WK=7402968844en_HK
dc.identifier.scopusauthoridNg, ML=15923631600en_HK
dc.identifier.scopusauthoridWei, WI=7403321552en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats